发明名称 |
N-11 TRUNCATED AMYLOID-BETA MONOCLONAL ANTIBODIES, COMPOSITIONS, METHODS AND USES |
摘要 |
PROBLEM TO BE SOLVED: To provide a monoclonal antibody which specifically recognizes an A&bgr;11-x peptide.SOLUTION: Monoclonal antibodies are obtained by priming with four species of peptides. The first two synthetic peptides comprise the first 5 to 7 human amino acids (AA) at the &bgr;-secretase 11 cleavage site: EVHHQ (KI)-C (human A&bgr;11 (6 to 8 AA)). The other two peptides for immunisation contain a mouse A&bgr;11 AA sequence; EVRHQ (KL)-C. This invention relates to antibodies, including specified portions or variants, specific for at least a human Amyloid-beta 11 N-terminal site, i.e. A&bgr;11-x peptides. It further provides methods of making and using the antibodies, including therapeutic formulations, administration and devices comprising the antibodies. |
申请公布号 |
JP2014208678(A) |
申请公布日期 |
2014.11.06 |
申请号 |
JP20140129164 |
申请日期 |
2014.06.24 |
申请人 |
JANSSEN PHARMACEUTICA NV |
发明人 |
MARC HUBERT MERCKEN;MARC MARIA PIERRE PELAGIE VANDERMEEREN |
分类号 |
C07K14/47;A61K39/395;A61P25/28;C07K16/18;C12N5/18;C12N5/20;C12N15/02;G01N33/53;G01N33/68 |
主分类号 |
C07K14/47 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|